| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0005 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0006 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0007 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |